Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04475640 · ClinicalTrials.gov registry record · NA

Cancer Genetic Testing in Ethnic Populations

A NA study of Malignant Solid Neoplasm and Breast Carcinoma, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
1,800
Enrollment target
2
Study locations

NCT04475640 is a NA study of Malignant Solid Neoplasm and Breast Carcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 1,800 participants, above the 1,131-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (59% higher). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04475640, a NA study of Malignant Solid Neoplasm and Breast Carcinoma, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
1,800 participants
Enrollment target
2
Study locations

Study Summary

This clinical trial examines the integration of cancer genetic testing in various ethnic populations. Studying individuals and families at risk of cancer may help identify cancer genes and other persons at risk. The information from this study may provide an opportunity for cancer risk stratification and individualized screening in these ethnic populations.

Interventions

  • PROCEDURE Biospecimen Collection
  • OTHER Genetic Testing

Study Locations (2)

Arizona

  • Mayo Clinic in Arizona - Scottsdale

Florida

  • Mayo Clinic in Florida - Jacksonville

Trial Details

FieldValue
Enrollment Target 1,800 participants
Start Date 2020-01-13
Est. Completion 2026-10-15
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT04475640

The ClinicalTrials.gov registry entry for NCT04475640 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,800 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,131-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (59% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 2 interventions - of which Biospecimen Collection is the first listed.

NCT04475640 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Arizona, Florida.

Frequently Asked Questions

What is clinical trial NCT04475640 about?

NCT04475640 is a clinical study titled "Cancer Genetic Testing in Ethnic Populations". This clinical trial examines the integration of cancer genetic testing in various ethnic populations. Studying individuals and families at risk of cancer may help identify cancer genes and other persons at risk. The information from this study may provide an opportunity for cancer risk stratificatio...

What is the current status of trial NCT04475640?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,800 participants. The study started on 2020-01-13. Estimated completion is 2026-10-15.

What conditions does trial NCT04475640 study?

This clinical trial studies the following conditions: Malignant Solid Neoplasm, Breast Carcinoma, Head and Neck Carcinoma, Malignant Female Reproductive System Neoplasm, Malignant Brain Neoplasm.

What interventions are being tested in trial NCT04475640?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Genetic Testing (OTHER).

Who is sponsoring clinical trial NCT04475640?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04475640 being conducted?

This trial has 2 study locations across Arizona, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.